-
-
-
-
-
-
-
Windtree Therapeutics, Inc. (WINT) reaches planned enrollment for Phase 2 SEISMiC study
-
-
-
-
-
-
-
Windtree Therapeutics, Inc. (WINT) Regains Nasdaq Compliance
-
-
-
-
-
-
-
Windtree Therapeutics, Inc. (WINT) Announces Leadership Transition Plan
-
-
-
-
-
-
-
Windtree Therapeutics, Inc. (WINT) Appoints Saundra Pelletier and Jed Latkin to its Board
-
479,047 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


